衡伟利，校聘副教授。

博士毕业于中国药科大学药学院药剂学专业，毕业后入职中国药科大学中药学院开展博士后工作，2023年9月入职南京工业大学药学院开展教学和科研工作。

研究方向：

1.中西药物制剂新剂型与新技术

2.药物晶体工程学

3.小分子药物凝胶化及其机制研究

主持科研项目/课题：

1.国家自然科学青年基金项目，82204636，2023.01-2025.12，主持

2.中国博士后科学基金面上项目，2021M693517，2021.06-2023.06，主持

3.江苏省博士后两项资助项目，2021.06-2023.06，主持

4.F28片剂的技术开发，主持

5.CS02搽剂的技术开发，主持

近5年代表性论文

[1]Heng W, Song Y, Luo M, Hu E, Wei Y, Gao Y, Pang Z, Zhang J*, Qian S*. Mechanistic insights into the crystallization of coamorphous drug systems.J. Control. Release, 2023, 354: 489-502.

[2]Zhu J, Wei Y, Zhang J, Qian S, Gao Y*,Heng W*. Are all poorly soluble drugs dissolved in deep eutectic solvents as true solutions?J. Colloid Interf. Sci., 2023, 645:813-822.

[3]Xia Y, Lu Y, Qian S, Zhang J, Gao Y*, Wei Y*,Heng W*. An efficient cocrystallization strategy for separation of dihydromyricetin from vine tea and enhanced its antibacterial activity for food preserving application.Food Chem., 2023, 426: 136525.

[4]Lin Z, Cao W, Zhang J, Wei Y, Qian S, Gao Y*,Heng W*. Specific separation of flavonoids isomers by defect modulated metal-organic framework HKUST-1: Experiment and density functional theory analysis.Appl. Surf. Sci., 2023, 631: 157592.

[5]Su M, Huang M, Pang Z, Wei Y, Gao Y, Zhang J*, Qian S*,Heng W*. Functionalin situformed deep eutectic solvents improving mechanical properties of powders by enhancing interfacial interactions.Int. J. Pharm., 2023, 642: 123181.

[6]Heng W, He X, Song Y, Han J, Pang Z, Qian S, Zhang J, Gao Y*, Wei Y*. Insights into cocrystallization and coamorphization engineering techniques in the delivery of traditional Chinese medicine: formation mechanism, solid-state characterization, and improved pharmaceutical properties.Cryst. Growth Des., 2022, 22: 5110-5134.

[7]Chen H, Zhang J, Qiao Q, Hu E, Wei Y, Pang Z, Gao Y, Qian S, Zhang J*,Heng W*. A novel soluble lornoxicam-sodium chelate monohydrate with improved plasticity and tabletability.Int. J. Pharm., 2022, 624: 122060.

[8]Shen P, Zhang C, Hu E, Pang Z, Gao Y, Qian S, Zhang J*, Wei Y*,Heng W*. Gelation switch of polyamorphic indomethacin depending on the thermal procedure.Eur. J. Pharm. Biopharm., 2022, 177: 249-259.

[9]Heng W, Su M, Cheng H, Shen P, Liang S, Zhang L, Wei Y, Gao Y, Zhang J*, Qian S*. Incorporation of complexation into a coamorphous system dramatically enhances dissolution and eliminates gelation of amorphous lurasidone hydrochloride.Mol. Pharm., 2020, 17: 84-97.

[10]Heng W, Wei Y, Xue Y, Cheng H, Zhang L, Zhang J, Gao Y*, Qian S*. Gel formation induced slow dissolution of amorphous indomethacin.Pharm. Res., 2019, 36: 159.

学术专著

1.《晶型药物研发理论与应用》，2019，化学工业出版社，副主编

2.《Novel Drug Delivery Systems for Chinese Medicines》，2021，Springer，参编

联系方式：hengweili@njtech.edu.cn